(Q67903784)
Statements
In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2 (English)
Schomburg A
Menzel T
Körfer A
Heer G
Dallmann I
Kirchner H
Poliwoda H
Atzpodien J
1 May 1992